{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,11]],"date-time":"2026-06-11T18:59:10Z","timestamp":1781204350592,"version":"3.54.1"},"reference-count":30,"publisher":"American Diabetes Association","issue":"9","license":[{"start":{"date-parts":[[2025,6,30]],"date-time":"2025-06-30T00:00:00Z","timestamp":1751241600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.diabetesjournals.org\/journals\/pages\/license"}],"funder":[{"name":"CCHMC Imaging Research Center"},{"DOI":"10.13039\/501100010311","name":"Core","doi-asserted-by":"crossref","award":["DK-020593"],"award-info":[{"award-number":["DK-020593"]}],"id":[{"id":"10.13039\/501100010311","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100010311","name":"Core","doi-asserted-by":"crossref","award":["DK-059637"],"award-info":[{"award-number":["DK-059637"]}],"id":[{"id":"10.13039\/501100010311","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100000062","name":"NIDDK","doi-asserted-by":"crossref","award":["DK-106364"],"award-info":[{"award-number":["DK-106364"]}],"id":[{"id":"10.13039\/100000062","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100000062","name":"NIDDK","doi-asserted-by":"crossref","award":["NCT05973799"],"award-info":[{"award-number":["NCT05973799"]}],"id":[{"id":"10.13039\/100000062","id-type":"DOI","asserted-by":"crossref"}]},{"name":"CRC"}],"content-domain":{"domain":["diabetesjournals.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2025,9,1]]},"abstract":"<jats:p>Short-term fasting (&amp;lt;24 h) is common in individuals with type 1 diabetes (T1D), but it is associated with increased risk of hypoglycemia. Current strategies to mitigate this risk include changing the timing and\/or dose of insulin; however, it is unclear whether counterregulatory hormone secretion is diminished, which would also contribute to this elevated risk. The current experiments were conducted to determine whether short-term fasting affects the hormonal and hepatic responses to insulin-induced hypoglycemia in those with T1D. Nine C-peptide\u2013negative individuals with T1D gave their informed consent to participate in a randomly assigned crossover-design metabolic trial. In one study, participants ate an isocaloric breakfast and lunch before undergoing a hyperinsulinemic\/hypoglycemic metabolic challenge in the evening (FED); in the other, they fasted before the hypoglycemic challenge (FAST). Immediately before insulin-induced hypoglycemia, glucagon concentrations were 43% lower in FAST compared with FED (31 \u00b1 5 and 54 \u00b1 6 pg\/mL, respectively; P &amp;lt; 0.001), and endogenous glucose production (EGP) was 28% lower (3.4 \u00b1 0.2 and 4.6 \u00b1 0.3 mg\/kg\/min, respectively; P &amp;lt; 0.01). During insulin-induced hypoglycemia, the area under the curve for glucagon remained lower by 42% in FAST compared with FED (1,598 \u00b1 229 and 2,768 \u00b1 422 pg\/mL \u2217 60 min, respectively; P &amp;lt; 0.01), as did EGP (41 \u00b1 4 and 78 \u00b1 12 mg\/kg \u2217 60 min, respectively; P = 0.01). These data demonstrate that fasting lowers glucagon concentrations and EGP under euglycemic\/normoinsulinemic metabolic conditions and during insulin-induced hypoglycemia. This reduction in metabolic flexibility, in addition to hyperinsulinemia, enhances susceptibility to fasting-induced low blood glucose in individuals with T1D and should be considered when developing strategies to avoid hypoglycemia.<\/jats:p>\n                  <jats:sec>\n                    <jats:title>ARTICLE HIGHLIGHTS<\/jats:title>\n                    <jats:p>Fasting is associated with increased risk of hypoglycemia in patients with type 1 diabetes (T1D); however, little is known about how the counterregulatory responses to low blood sugar are affected under these metabolic conditions. During insulin-induced hypoglycemia, fasting (compared with eating normal meals for breakfast and lunch) glucagon concentrations were lower by 42% and endogenous glucose production by 47% in individuals with T1D. The secretion of other counterregulatory hormones during hypoglycemia was not affected by fasting (e.g., epinephrine, norepinephrine, cortisol). Fasting diminishes glucagon levels under hypoglycemic conditions in those with T1D, which may increase their susceptibility to hypoglycemia.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.2337\/db25-0251","type":"journal-article","created":{"date-parts":[[2025,6,30]],"date-time":"2025-06-30T11:07:41Z","timestamp":1751281661000},"page":"1687-1694","update-policy":"https:\/\/doi.org\/10.2337\/ada-journal-policies","source":"Crossref","is-referenced-by-count":2,"title":["Fasting Lowers Glucagon Levels Under Basal Conditions and During Insulin-Induced Hypoglycemia in Individuals With Type 1 Diabetes"],"prefix":"10.2337","volume":"74","author":[{"given":"Nicole","family":"Sheanon","sequence":"first","affiliation":[{"name":"Division of Pediatric Endocrinology, Department of Pediatrics, Cincinnati Children\u2019s Hospital Medical Center, University of Cincinnati College of Medicine 1 , Cincinnati, OH"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shana O.","family":"Warner","sequence":"additional","affiliation":[{"name":"Division of Endocrinology, Diabetes and Metabolism, Department of Internal Medicine, University of Cincinnati College of Medicine 2 , Cincinnati, OH"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yufei","family":"Dai","sequence":"additional","affiliation":[{"name":"Division of Endocrinology, Diabetes and Metabolism, Department of Internal Medicine, University of Cincinnati College of Medicine 2 , Cincinnati, OH"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nat H.","family":"Whitsett","sequence":"additional","affiliation":[{"name":"Division of Endocrinology, Diabetes and Metabolism, Department of Internal Medicine, University of Cincinnati College of Medicine 2 , Cincinnati, OH"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shahriar","family":"Arbabi","sequence":"additional","affiliation":[{"name":"Division of Endocrinology, Diabetes and Metabolism, Department of Internal Medicine, University of Cincinnati College of Medicine 2 , Cincinnati, OH"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Blair","family":"Hoeting","sequence":"additional","affiliation":[{"name":"Division of Endocrinology, Diabetes and Metabolism, Department of Internal Medicine, University of Cincinnati College of Medicine 2 , Cincinnati, OH"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shailendra B.","family":"Patel","sequence":"additional","affiliation":[{"name":"Division of Endocrinology, Diabetes and Metabolism, Department of Internal Medicine, University of Cincinnati College of Medicine 2 , Cincinnati, OH"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Diana","family":"Lindquist","sequence":"additional","affiliation":[{"name":"Imaging Research Center, Departments of Radiology and Pediatrics, Cincinnati Children\u2019s Hospital Medical Center, University of Cincinnati College of Medicine 3 , Cincinnati, OH"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0004-7548-289X","authenticated-orcid":false,"given":"Jason J.","family":"Winnick","sequence":"additional","affiliation":[{"name":"Division of Endocrinology, Diabetes and Metabolism, Department of Internal Medicine, University of Cincinnati College of Medicine 2 , Cincinnati, OH"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1167","published-online":{"date-parts":[[2025,6,30]]},"reference":[{"key":"2026061114275828400_B1","doi-asserted-by":"crossref","first-page":"3169","DOI":"10.2337\/db08-1084","article-title":"The barrier of hypoglycemia in diabetes","volume":"57","author":"Cryer","year":"2008","journal-title":"Diabetes"},{"key":"2026061114275828400_B2","first-page":"E651","article-title":"Insulin, glucagon, and catecholamines in prevention of hypoglycemia during fasting","volume":"256","author":"Boyle","year":"1989","journal-title":"Am J Physiol"},{"key":"2026061114275828400_B3","first-page":"E844","article-title":"Contributions of gluconeogenesis and glycogenolysis during glucose counterregulation in normal humans","volume":"256","author":"Lecavalier","year":"1989","journal-title":"Am J Physiol"},{"key":"2026061114275828400_B4","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1126\/science.182.4108.171","article-title":"Lack of glucagon response to hypoglycemia in diabetes: evidence for an intrinsic pancreatic alpha cell defect","volume":"182","author":"Gerich","year":"1973","journal-title":"Science"},{"key":"2026061114275828400_B5","doi-asserted-by":"crossref","first-page":"930","DOI":"10.1001\/jamainternmed.2017.0936","article-title":"Effect of alternate-day fasting on weight loss, weight maintenance, and cardioprotection among metabolically healthy obese adults: a randomized clinical trial","volume":"177","author":"Trepanowski","year":"2017","journal-title":"JAMA Intern Med"},{"key":"2026061114275828400_B6","doi-asserted-by":"crossref","first-page":"878","DOI":"10.1016\/j.cmet.2020.02.011","article-title":"Alternate day fasting improves physiological and molecular markers of aging in healthy, non-obese humans","volume":"31","author":"Stekovic","year":"2020","journal-title":"Cell Metab"},{"key":"2026061114275828400_B7","doi-asserted-by":"crossref","first-page":"2306","DOI":"10.2337\/diacare.27.10.2306","article-title":"A population-based study of diabetes and its characteristics during the fasting month of Ramadan in 13 countries: results of the epidemiology of diabetes and Ramadan 1422\/2001 (EPIDIAR) study","volume":"27","author":"Salti","year":"2004","journal-title":"Diabetes Care"},{"key":"2026061114275828400_B8","first-page":"482","article-title":"Treatment of type 1 diabetes with insulin lispro during Ramadan","volume":"27","author":"Kadiri","year":"2001","journal-title":"Diabetes Metab"},{"key":"2026061114275828400_B9","doi-asserted-by":"crossref","first-page":"2305","DOI":"10.2337\/diacare.28.9.2305","article-title":"Recommendations for management of diabetes during Ramadan","volume":"28","author":"Al-Arouj","year":"2005","journal-title":"Diabetes Care"},{"key":"2026061114275828400_B10","doi-asserted-by":"crossref","first-page":"2236","DOI":"10.1172\/JCI79895","article-title":"Hepatic glycogen can regulate hypoglycemic counterregulation via a liver-brain axis","volume":"126","author":"Winnick","year":"2016","journal-title":"J Clin Invest"},{"key":"2026061114275828400_B11","doi-asserted-by":"crossref","first-page":"E914","DOI":"10.1152\/ajpendo.00501.2020","article-title":"Liver glycogen-induced enhancements in hypoglycemic counterregulation require neuroglucopenia","volume":"320","author":"Warner","year":"2021","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"2026061114275828400_B12","doi-asserted-by":"crossref","first-page":"e169789","DOI":"10.1172\/jci.insight.169789","article-title":"Short-term fasting lowers glucagon levels under euglycemic and hypoglycemic conditions in healthy humans","volume":"8","author":"Warner","year":"2023","journal-title":"JCI Insight"},{"key":"2026061114275828400_B13","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1093\/ajcn\/51.2.241","article-title":"A new predictive equation for resting energy expenditure in healthy individuals","volume":"51","author":"Mifflin","year":"1990","journal-title":"Am J Clin Nutr"},{"key":"2026061114275828400_B14","first-page":"E126","article-title":"A negative arterial-portal venous glucose gradient increases net hepatic glucose uptake in euglycemic dogs","volume":"277","author":"Galassetti","year":"1999","journal-title":"Am J Physiol"},{"key":"2026061114275828400_B15","doi-asserted-by":"crossref","first-page":"2442","DOI":"10.3390\/nu11102442","article-title":"Effectiveness of intermittent fasting and time-restricted feeding compared to continuous energy restriction for weight loss","volume":"11","author":"Rynders","year":"2019","journal-title":"Nutrients"},{"key":"2026061114275828400_B16","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/j.arr.2016.10.005","article-title":"Impact of intermittent fasting on health and disease processes","volume":"39","author":"Mattson","year":"2017","journal-title":"Ageing Res Rev"},{"key":"2026061114275828400_B17","doi-asserted-by":"crossref","first-page":"656346","DOI":"10.3389\/fendo.2021.656346","article-title":"Impact of a single 36 hours prolonged fasting period in adults with type 1 diabetes - a cross-over controlled trial","volume":"12","author":"Moser","year":"2021","journal-title":"Front Endocrinol (Lausanne)"},{"key":"2026061114275828400_B18","first-page":"E402","article-title":"Effects of physiological hyperinsulinemia on counterregulatory response to prolonged hypoglycemia in normal humans","volume":"267","author":"Davis","year":"1994","journal-title":"Am J Physiol"},{"key":"2026061114275828400_B19","doi-asserted-by":"crossref","first-page":"1490","DOI":"10.2337\/diacare.26.5.1490","article-title":"Intensive replacement of basal insulin in patients with type 1 diabetes given rapid-acting insulin analog at mealtime: a 3-month comparison between administration of NPH insulin four times daily and glargine insulin at dinner or bedtime","volume":"26","author":"Rossetti","year":"2003","journal-title":"Diabetes Care"},{"key":"2026061114275828400_B20","doi-asserted-by":"crossref","first-page":"1162","DOI":"10.2337\/diacare.21.7.1162","article-title":"Optimization of evening insulin dose in patients using the short-acting insulin analog lispro","volume":"21","author":"Ahmed","year":"1998","journal-title":"Diabetes Care"},{"key":"2026061114275828400_B21","doi-asserted-by":"crossref","first-page":"1735","DOI":"10.1073\/pnas.73.5.1735","article-title":"Kinetics of glucagon in man: effects of starvation","volume":"73","author":"Fisher","year":"1976","journal-title":"Proc Natl Acad Sci U S A"},{"key":"2026061114275828400_B22","doi-asserted-by":"crossref","first-page":"E474","DOI":"10.1152\/ajpendo.00236.2015","article-title":"Glucagon sensitivity and clearance in type 1 diabetes: insights from in\u00a0vivo and in silico experiments","volume":"309","author":"Hinshaw","year":"2015","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"2026061114275828400_B23","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1007\/s00125-013-3148-x","article-title":"Glucagon clearance is regulated by nutritional state: evidence from experimental studies in mice","volume":"57","author":"Zhou","year":"2014","journal-title":"Diabetologia"},{"key":"2026061114275828400_B24","doi-asserted-by":"crossref","first-page":"E71","DOI":"10.1152\/ajpendo.00488.2020","article-title":"Assessment of individual and standardized glucagon kinetics in healthy humans","volume":"320","author":"Laurenti","year":"2021","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"2026061114275828400_B25","doi-asserted-by":"crossref","first-page":"1641","DOI":"10.2337\/db24-0305","article-title":"Glucagon clearance is decreased in chronic kidney disease but preserved in liver cirrhosis","volume":"73","author":"Gr\u00f8ndahl","year":"2024","journal-title":"Diabetes"},{"key":"2026061114275828400_B26","doi-asserted-by":"crossref","first-page":"1175","DOI":"10.1016\/S0021-9258(18)81278-9","article-title":"Glucokinase and hexokinase in liver in relation to glycogen synthesis","volume":"238","author":"Vinuela","year":"1963","journal-title":"J Biol Chem"},{"key":"2026061114275828400_B27","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1172\/JCI117727","article-title":"Impaired net hepatic glycogen synthesis in insulin-dependent diabetic subjects during mixed meal ingestion. A 13C nuclear magnetic resonance spectroscopy study","volume":"95","author":"Hwang","year":"1995","journal-title":"J Clin Invest"},{"key":"2026061114275828400_B28","doi-asserted-by":"crossref","first-page":"960","DOI":"10.2337\/dc20-2684","article-title":"The SimpliciT1 study: a randomized, double-blind, placebo-controlled phase 1b\/2 adaptive study of TTP399, a hepatoselective glucokinase activator, for adjunctive treatment of type 1 diabetes","volume":"44","author":"Klein","year":"2021","journal-title":"Diabetes Care"},{"key":"2026061114275828400_B29","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/j.metabol.2003.09.013","article-title":"The metabolic response to ingestion of proline with and without glucose","volume":"53","author":"Nuttall","year":"2004","journal-title":"Metabolism"},{"key":"2026061114275828400_B30","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1007\/s00125-006-0519-6","article-title":"Effect of the amino acid alanine on glucagon secretion in non-diabetic and type 1 diabetic subjects during hyperinsulinaemic euglycaemia, hypoglycaemia and post-hypoglycaemic hyperglycaemia","volume":"50","author":"Porcellati","year":"2007","journal-title":"Diabetologia"}],"container-title":["Diabetes"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/diabetesjournals.org\/diabetes\/article-pdf\/74\/9\/1687\/835932\/db250251.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/diabetesjournals.org\/diabetes\/article-pdf\/74\/9\/1687\/835932\/db250251.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,11]],"date-time":"2026-06-11T18:28:05Z","timestamp":1781202485000},"score":1,"resource":{"primary":{"URL":"https:\/\/diabetesjournals.org\/diabetes\/article\/74\/9\/1687\/162859\/Fasting-Lowers-Glucagon-Levels-Under-Basal"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6,30]]},"references-count":30,"journal-issue":{"issue":"9","published-online":{"date-parts":[[2025,6,30]]},"published-print":{"date-parts":[[2025,9,1]]}},"URL":"https:\/\/doi.org\/10.2337\/db25-0251","relation":{},"ISSN":["0012-1797","1939-327X"],"issn-type":[{"value":"0012-1797","type":"print"},{"value":"1939-327X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,6,30]]}}}